Harry Dawson

Harry Dawson is an experienced Scientific R&D Project Manager at Cherry Biotech, overseeing international collaborations and technology validation since May 2023. Prior roles include Industrial PhD Researcher in BioEngineering at MedinCell, where work focused on microfluidics for long-acting injectables, and research internships at Institut Curie and ESPCI Paris, contributing to high-throughput screening technologies and diagnostic devices, respectively. Previous experience in the medical device industry includes roles as a Sales Associate and Technical Representative at SRA Developments Ltd, and a Global Education Senior Peer Adviser at Keele University. Educational qualifications comprise a Master of Business Administration from IAE France, a Master's in Biomedical/Medical Engineering from Arts et Métiers, and a Bachelor of Science in Biological Sciences from Keele University, alongside ongoing studies in Biology at Western Sydney University.